CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 41 enrolled
Drug / intervention
Sertraline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02797808
NCT02797808Phase 2Completed
CompareCT.gov

Effects of Sertraline on Brain Connectivity in Adolescents With OCD (Obsessive-Compulsive Disorder)

University of Minnesota·interventional·Posted Jun 13, 2016·Updated Jan 5, 2021

In Brief

A Phase 2 clinical trial evaluating Sertraline and No Intervention for OCD. Completed, enrolled 41 participants across 1 site.

Detailed Summary

The investigators will examine how treatment with sertraline for 12 weeks impacts frontal-striatal-thalamic circuitry (FSTC) in this OCD sample.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOCD
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 13, 2016
Enrollment StartAug 1, 2013
Primary CompletionJan 31, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 10.1 years ago

Interventions

Sertralinedrug

Impact of sertraline on functional brain connectivity

No Interventionother

Healthy control non-intervention